Institute Seminars at the Institute for Cancer Research Autumn 2017

Kempkes RWM, Nikolaou C, Nabhan M, Saidu NEB (2024)
IUIS 2023: yEFIS workshop on career development and code-switching
Eur J Immunol, e2451155 (in press)
DOI 10.1002/eji.202451155, PubMed 38676471

Fleischer T, Haugen MH, Ankill J, Silwal-Pandit L, Børresen-Dale AL, Hedenfalk I, Hatschek T, Tost J, Engebraaten O, Kristensen VN (2024)
An integrated omics approach highlights how epigenetic events can explain and predict response to neoadjuvant chemotherapy and bevacizumab in breast cancer
Mol Oncol (in press)
DOI 10.1002/1878-0261.13656, PubMed 38671580

Martin KE, Hammer Q, Perica K, Sadelain M, Malmberg KJ (2024)
Engineering immune-evasive allogeneic cellular immunotherapies
Nat Rev Immunol (in press)
DOI 10.1038/s41577-024-01022-8, PubMed 38658708

Esperon P, Neffa F, Pavicic W, Spirandelli F, Alvarez K, Mullins MJ, Rossi BM, Góngora E Silva RF, Vaccaro C, Lopéz-Köstner F, Rugeles J, Valle AD, Dominguez-Valentin M (2024)
A comprehensive characterization of the spectrum of MUTYH germline pathogenic variants in Latin America
Fam Cancer (in press)
DOI 10.1007/s10689-024-00382-3, PubMed 38687439

Kempkes RWM, Nikolaou C, Nabhan M, Saidu NEB (2024)
IUIS 2023: yEFIS workshop on career development and code-switching
Eur J Immunol, e2451155 (in press)
DOI 10.1002/eji.202451155, PubMed 38676471

Dodd DO, Mechaussier S, Yeyati PL, McPhie F, Anderson JR, Khoo CJ, Shoemark A, Gupta DK, Attard T, Zariwala MA, Legendre M, Bracht D, Wallmeier J, Gui M, Fassad MR, Parry DA, Tennant PA, Meynert A, Wheway G, Fares-Taie L, Black HA, Mitri-Frangieh R, Faucon C, Kaplan J, Patel M et al. (2024)
Ciliopathy patient variants reveal organelle-specific functions for TUBB4B in axonemal microtubules
Science, 384 (6694), eadf5489
DOI 10.1126/science.adf5489, PubMed 38662826